Product Overview: Fareston
Fareston 60mg Orion Corp is a toremifene citrate pharmaceutical preparation manufactured by Orion Corporation for laboratory research applications. Toremifene belongs to the selective estrogen receptor modulator (SERM) class, functioning as a competitive antagonist at estrogen receptors with tissue-selective activity profiles in preclinical models. This compound demonstrates mixed agonist/antagonist properties across different target tissues, making it valuable for researchers examining estrogen receptor signalling pathways and hormonal modulation mechanisms.
The pharmaceutical-grade formulation from Orion Corporation provides researchers with consistent dosing standards for experimental protocols. Each tablet contains 60mg of toremifene citrate alongside pharmaceutical excipients necessary for tablet formation and stability. Stroid UK Shop stocks this preparation to support UK laboratory investigations into SERM pharmacology and estrogen receptor research applications.
Laboratory Applications
Research teams utilise Fareston 60mg preparations to study estrogen receptor modulation across diverse cellular and tissue models. The compound’s selective activity profile enables investigation of tissue-specific estrogen responses, particularly in breast cancer cell lines where toremifene demonstrates antagonistic properties. Metabolic research applications include examination of bone density regulation pathways and lipid metabolism modulation in laboratory models.
Comparative studies between toremifene and other SERMs provide insights into structure-activity relationships within this compound class. Researchers investigating toremifene research applications often examine its longer half-life properties relative to tamoxifen, enabling extended observation periods in chronic treatment protocols. Cross-disciplinary research encompasses oncology, endocrinology, and reproductive biology studies utilising this pharmaceutical preparation.
Advanced research protocols examine toremifene’s interaction with other signalling pathways, including its effects on growth factor expression and cell cycle regulation. Teams studying hormonal therapy resistance mechanisms frequently incorporate this compound alongside SARM research compounds and peptide preparations for comprehensive multi-target investigations.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Toremifene Citrate |
| Dosage Strength | 60mg per tablet |
| Manufacturer | Orion Corporation |
| CAS Number | 89778-27-8 (citrate salt) |
| Molecular Formula | C₂₆H₂₈ClNO·C₆H₈O₇ |
| Storage Requirements | Room temperature, dry environment |
Research Compliance Statement
Fareston 60mg Orion Corp is supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional oversight, proper handling protocols, and disposal procedures according to local regulations. Purchase and use should align with legitimate research objectives and institutional review board approvals where applicable.
